Fresenius (NYSE:FMS) business group Fresenius Kabi said today it inked a 5-year exclusive distribution deal with Terumo Corp. (TYO:4543) to launch Fresenius’ CATSmart autotransfusion system in the US. Autotransfusion devices are designed to re-infuse a patient’s own lost blood during surgery. Fresenius said the CATSmart is its next-gen continuous autotransfusion system, featuring continuous-flow technology, 3 wash programs, […]
Blood Management
CytoSorbents gains on German reimbursement win
CytoSorbents Corp. (NSDQ:CTSO) shares jumped 9% to $5.35 apiece today after the company reported that it landed a permanent reimbursement procedure code for its CytoSorb therapy in Germany. The Monmouth Junction, N.J.-based company developed its blood purification therapy to treat inflammation in critically-ill patients and for use during cardiac surgery. CytoSorb is an extracorporeal cytokine […]
Abbott i-Stat handheld blood tester wins CE Mark
Abbott (NYSE:ABT) said today it won CE Mark approval in the European Union for its i-Stat Alinity handheld blood testing platform. The i-Stat Alinity system is designed to perform a wide range of blood tests and analyses, including blood chemistries and blood markers. The company claims the device has the “largest menu of blood tests […]
Fires prompt warning on Medtronic’s Bellco Formula dialysis device
Medtronic (NYSE:MDT) today released an urgent field safety notice after receiving reports of 3 fires related to its Formula hemodialysis machines, though no injuries were reported related to the fires. Bellco, who makes the devices, was acquired by Medtronic in February for an undisclosed amount, and folded into a newly created renal care solutions division. The […]
Baxter touts blood purification efficiency in EBP studies
Baxter (NYSE:BAX) today released data from 2 studies on extracorporeal blood purification studies, touting the blood purification method’s ability to remove harmful molecules linked to inflammation. Extracorporeal blood purification takes place outside the body, with blood passing through a membrane within an extracorporeal circuit to filter harmful molecules and waste products out of the blood, the […]
Hill-Rom enters home monitoring arena with Welch Allyn hypertension program
Hill-Rom (NYSE:HRC) said today it is entering the home monitoring field as its subsidiary Welch Allyn launches its Home Hypertension program. The program will allow patients to monitor their health at home using Welch Allyn’s home blood pressure monitor, which can sync to a smartphone app to pursue healthy blood pressure goals. The smartphone app is […]
Baxter touts data on home peritoneal dialysis
Baxter (NYSE:BAX) today released data on its Sharesource remote patient monitoring and home-use Amia automated peritonial dialysis systems, touting its ability to improve early detection of adverse issue issues and faster treatment. Data on the platforms was presented at the American Society of Nephrology’s annual Kidney Week meeting last week in Chicago. Data from a case […]
Seventh Sense raises $10m in Series C
Seventh Sense Biosystems said today it raised $10 million in a Series C funding round to support its Tap push-button blood collection device, as well as new product development and increasing production capacity. Joining the round are existing investors Novartis, Laboratory Corp of America Holdings, Polaris Partners and Flagship Ventures. “We’re bolstered by the confidence our […]
Aethlon’s blood filtration device as broad countermeasure for infectious diseases
In the midst of a devastating global crisis 2 years ago, a Ugandan physician was infected with Ebola in Sierra Leone as he was treating patients. He was hospitalized at the Frankfurt University Hospital and 12 days later he was unconscious, suffering from multiple organ failure. By the time Aethlon Medical (NSDQ:AEMD) got permission to use […]
Haemonetics tops Q2 earnings forecast by 11c
Haemonetics (NYSE:HAE) yesterday posted fiscal 2nd-quarter numbers that topped expectations on Wall Street by more than a dime, despite flat sales growth, as the company executes a reorganization plan. The Braintree, Mass.-based blood management company posted profits of $19.8 million, or 38¢ per share, on sales of $220.3 million for the 3 months ended Oct. 1, […]
Hemodialysis dev InnAVasc raises $2.2m
InnAVasc Medical said it raised $2.15 million in a new round of equity financing, according to an SEC filing posted today . InnAVasc is developing devices designed for vascular access during hemodialysis. The company’s 1st device is an arteriovenous graft modification which includes 2 multilayer cannulation chambers and low-bleed tech, designed to be resistant to […]